Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01911130 · ClinicalTrials.gov registry record

Longitudinal Study of Outcomes Measures in ALS Trials

A clinical trial, sponsored by Massachusetts General Hospital.

Completed
Registry status
100
Enrollment target

NCT01911130: Completed study, sponsored by Massachusetts General Hospital.

NCT01911130 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01911130 has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
100 participants
Enrollment target

Study Summary

A new strength measurement device called Accurate Test of Limb Isometric Strength (ATLIS) was developed to precisely and conveniently measure static limb strength in patients with ALS. The investigators will compare ATLIS data with data from two commonly used ALS outcomes measures, the ALS Functional Rating Scale-Revised (ALSFRS-R) and slow vital capacity (SVC) in a prospective, longitudinal study. All three outcomes measures will be performed on 100 subjects collected preferably at bi-monthly clinic visits during the study period.

Primary Outcome

ATLIS measures isometric strength in 12 muscle groups in the arms and legs. The subject is tested seated in a specially designed chairs with adjustable uprights. The subject's limb is placed in a standard position and maximal force is exerted on the wireless load cell fixed to the upright. Strength data is digitally captured and expressed as a percentage of expected normal.

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2013-07
Est. Completion 2016-03
Massachusetts General Hospital

2,032 total trials

What the finished NCT01911130 record still lists

NCT01911130 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01911130 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01911130 about?

NCT01911130 is a clinical study titled "Longitudinal Study of Outcomes Measures in ALS Trials". A new strength measurement device called Accurate Test of Limb Isometric Strength (ATLIS) was developed to precisely and conveniently measure static limb strength in patients with ALS. The investigators will compare ATLIS data with data from two commonly used ALS outcomes measures, the ALS Functiona...

What is the current status of trial NCT01911130?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2013-07. Estimated completion is 2016-03.

Who is sponsoring clinical trial NCT01911130?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01911130, the US trial registry maintained by the National Library of Medicine. NCT01911130 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.